Literature DB >> 17869373

Assessment of low-grade hepatic encephalopathy: a critical analysis.

Gerald Kircheis1, Wolfgang E Fleig, Roman Görtelmeyer, Susanne Grafe, Dieter Häussinger.   

Abstract

BACKGROUND/AIMS: The value of paper-pencil tests and West-Haven-criteria for assessment of low-grade hepatic encephalopathy under conditions of a randomized, double-blind, placebo-controlled, clinical trial was evaluated in a cohort of 217 cirrhotics.
METHODS: Patients were graded at least twice clinically for severity of hepatic encephalopathy and tested concomitantly with a recommended psychometric test battery.
RESULTS: Re-evaluation of the study documentation showed that at study entry 33% and during the study even 50% of the patients were wrongly allocated to minimal or overt hepatic encephalopathy. Despite the participating physicians' training, 31% of the number-connection-tests-A, 20% of the number-connection-tests-B and 28% of the line-tracing-test were in retrospect considered invalid by an independent psychologist. Neither the Portosystemic-Encephalopathy-Syndrome (PSE) test nor the Psychometric-Hepatic-Encephalopathy-Sum (PHES)-score reliably picked up clinical improvement in the individual patient. Although these test scores could statistically differentiate between patients with minimal and overt hepatic encephalopathy, the clinical classification of individual patients into one of the groups will have a high rate of error. The PHES-Score was less balanced than the score derived from the PSE-Syndrome-Test.
CONCLUSIONS: Inaccuracies in conducting paper-pencil tests together with the subjectivity and incorrectness of clinical HE-grading question the usefulness of West-Haven-criteria and paper-pencil tests including related scores for quantification of low-grade HE at least in multicenter approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869373     DOI: 10.1016/j.jhep.2007.05.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Covert hepatic encephalopathy: agreement and predictive validity of different indices.

Authors:  Sara Montagnese; Esmeralda Balistreri; Sami Schiff; Michele De Rui; Paolo Angeli; Giacomo Zanus; Umberto Cillo; Giancarlo Bombonato; Massimo Bolognesi; David Sacerdoti; Angelo Gatta; Carlo Merkel; Piero Amodio
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 3.  Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.

Authors:  Dileep K Atluri; Ravi Prakash; Kevin D Mullen
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 4.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

5.  Saccadic latency in hepatic encephalopathy: a pilot study.

Authors:  Florian Krismer; Jonathan C P Roos; Melanie Schranz; Ivo W Graziadei; Sergei Mechtcheriakov; Wolfgang Vogel; R H S Carpenter; Heinz Zoller
Journal:  Metab Brain Dis       Date:  2010-09-18       Impact factor: 3.584

6.  Covert hepatic encephalopathy: does the mini-mental state examination help?

Authors:  Michela Corrias; Matteo Turco; Michele D Rui; Angelo Gatta; Paolo Angeli; Carlo Merkel; Piero Amodio; Sami Schiff; Sara Montagnese
Journal:  J Clin Exp Hepatol       Date:  2014-01-24

Review 7.  Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical use.

Authors:  Mads Kingo Guldberg Hansen; Kristoffer Kjærgaard; Lotte Lindgreen Eriksen; Lea Ladegaard Grønkjær; Anne Catrine Daugaard Mikkelsen; Thomas Damgaard Sandahl; Hendrik Vilstrup; Karen Louise Thomsen; Mette Munk Enok Lauridsen
Journal:  Metab Brain Dis       Date:  2022-02-01       Impact factor: 3.584

8.  Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis.

Authors:  Dong Wu; Shu-Mei Wu; Jie Lu; Ying-Qun Zhou; Ling Xu; Chuan-Yong Guo
Journal:  Gastroenterol Res Pract       Date:  2013-04-03       Impact factor: 2.260

9.  A current review of the diagnostic and treatment strategies of hepatic encephalopathy.

Authors:  Z Poh; P E J Chang
Journal:  Int J Hepatol       Date:  2012-10-21

10.  A Methodology to Generate Longitudinally Updated Acute-On-Chronic Liver Failure Prognostication Scores From Electronic Health Record Data.

Authors:  Jin Ge; Nader Najafi; Wendi Zhao; Ma Somsouk; Margaret Fang; Jennifer C Lai
Journal:  Hepatol Commun       Date:  2021-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.